News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Industry News Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol January 21, 2016
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Industry News FDA approves Repatha to treat certain patients with high cholesterol August 28, 2015
News Daily News Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients August 06, 2015
News Daily News IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy Yael L. Maxwell June 05, 2015